Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

A Phase I, First-in-Human Study Evaluating the Safety and Preliminary Antileukemia Activity of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Other CD123-Positive Hematologic Malignancies

Naval G. Daver, MD, Harry P. Erba, MDPhD, Nikolaos Papadantonakis, MDPhDMSc, Daniel J. DeAngelo, MD, Eunice S. Wang, MD, Marina Y. Konopleva, MD PhD, Callum M. Sloss, PhD, Kerry Culm-Merdek, Patrick A. Zweidler-McKay, MD PhD, Hagop M. Kantarjian, MD

Blood (2018) 132 (Supplement 1): 27.

https://doi.org/10.1182/blood-2018-99-112955

Published: 2018

Journal Articles

Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart ® Molecule for T-Cell Redirected Therapy

Blood (2018) 132 (Supplement 1): 2738.

https://doi.org/10.1182/blood-2018-99-112615

Published: 2018

Journal Articles

A Retrospective Review of Tocilizumab for the Management of Blinatumomab (a Bispecific T Cell Engager)-Induced Cytokine Release Syndrome (CRS)

Jessica Choudhry, PharmD, RPh, Mandy Parson, BSN, Jacqueline Wright

Blood (2018) 132 (Supplement 1): 5211.

https://doi.org/10.1182/blood-2018-99-117353

Published: 2018

Journal Articles

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Jacopo Mariotti, Valerio Maisano, MD, Pierre Jean Weiller, MDPhD, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 1984.

https://doi.org/10.1182/blood.V130.Suppl_1.1984.1984

Published: 2017

Journal Articles

A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia

Xian Zhang, PhD, Junfang Yang, MD, Gailing Zhang, MD, Peggy (Pei-Hua) Lu, MD

Blood (2017) 130 (Supplement 1): 1369.

https://doi.org/10.1182/blood.V130.Suppl_1.1369.1369

Published: 2017

Journal Articles

Quinine-Induced Thrombotic Microangiopathy (Q-TMA): Frequency, Presenting Features, Outcomes

Evaren E Page, MPH, Sara K. Vesely, PhD, James N. George, MD

Blood (2016) 128 (22): 1381.

https://doi.org/10.1182/blood.V128.22.1381.1381

Published: 2016

Journal Articles

Fight for Platelets: AML Diagnosed during Dengue Fever: Case Report

Laura Yolanda Chialanza Garcia, MD, Daniela Ferreira Dias, MD, Marcelo Bellesso, MD, Juliano Cordova Vargas, MD, Milton A. F. Aranha, MD, Annelise C. Wengerkievicz Lopes, MD, Rodrigo Santucci, MD

Blood (2015) 126 (23): 4903.

https://doi.org/10.1182/blood.V126.23.4903.4903

Published: 2015

Journal Articles

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Erden Atilla, MD, Pinar Ataca, MD, Sinem Civriz Bozdag, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Bengu Nisa Akay, MD, Hatice Sanli, MD, Pervin Topcuoglu, MD, Muhit Ozcan, MD, Gunhan Gurman, MD, Osman Ilhan

Blood (2015) 126 (23): 5062.

https://doi.org/10.1182/blood.V126.23.5062.5062

Published: 2015

Journal Articles

Low Dose Steroids Can Alleviate Blinatumomab-Associated Toxicities without Negatively Impacting Treatment Efficacy

Shahram Mori, MD PhD, Rebecca Jean Nelson, PharmD, Rushang D. Patel, MDPhD, Wesam B. Ahmed, MD PhD

Blood (2015) 126 (23): 4875.

https://doi.org/10.1182/blood.V126.23.4875.4875

Published: 2015

Journal Articles

First-in-Man CD123-Specific Chimeric Antigen Receptor-Modified T Cells for the Treatment of Refractory Acute Myeloid Leukemia

Yi Luo, Lung-Ji Chang, PhD, Yongxian Hu, MD, Lujia Dong, Guoqing Wei, He Huang, MD PhD

Blood (2015) 126 (23): 3778.

https://doi.org/10.1182/blood.V126.23.3778.3778

Published: 2015

Journal Articles

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Jordan M Morton, MD, Evaren E Page, MPH, Nathan W Liles, MD MPH, James N. George, MD

Blood (2015) 126 (23): 4651.

https://doi.org/10.1182/blood.V126.23.4651.4651

Published: 2015

Journal Articles

Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Mustafa Merter, MD, Erden Atilla, MD, Ugur Sahin, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, MD, Muhit Ozcan, MD, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD

Blood (2015) 126 (23): 5456.

https://doi.org/10.1182/blood.V126.23.5456.5456

Published: 2015

Journal Articles

Final Results and Follow-up of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (aka MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Jennifer A. Woyach, MD, Farrukh Awan, MD MS, Ian Flinn, Jesus G. Berdeja, MD, Elizabeth A Wiley, Sharmeen Mansoor, Ying Huang, MA, MS, Gerard Lozanski, MD, Paul A. Foster, MD, John C. Byrd, MD

Blood (2014) 124 (21): 1993.

https://doi.org/10.1182/blood.V124.21.1993.1993

Published: 2014

Journal Articles

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Michael (Luhua) Wang, MD, Ajay K. Nooka, MD MPH, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth O'Donnell, MD, Jatin Shah, MD, Donna M. Weber, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, David Avigan, MD, Noopur Raje, MD

Blood (2014) 124 (21): 4737.

https://doi.org/10.1182/blood.V124.21.4737.4737

Published: 2014

Journal Articles

Clinical Characteristics of Rituximab Intolerance in Patients with Waldenstrom's Macroglobulinemia

Sandra Kanan, NP, Kirsten Meid, MPH, Steven P Treon, MD MA, PhD, Jorge J. Castillo, MD

Blood (2014) 124 (21): 2610.

https://doi.org/10.1182/blood.V124.21.2610.2610

Published: 2014

Journal Articles

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma

Ayed O Ayed, MD, Jan S Moreb, MD, Jack W. Hsu, MD, John W Hiemenz, MD, John R Wingard, MD, Maxim Norkin, MD PhD

Blood (2014) 124 (21): 5761.

https://doi.org/10.1182/blood.V124.21.5761.5761

Published: 2014

Journal Articles

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Tahir Mehmood, MD, Khine Swe, MD, Gopimohan Das, MD, Aysegul Gozu, MD MPH, Michael Auerbach, MD, Sein Aung, MD

Blood (2014) 124 (21): 4028.

https://doi.org/10.1182/blood.V124.21.4028.4028

Published: 2014

Journal Articles

Relevance of a One-Year Maintenance Therapy with Interleukin-2 in the Treatment of Childhood Acute Myeloid Leukemia: Results from the French Multicenter, Phase III, Randomized Controlled Sfce Trial, ELAM02

Arnaud Petit, MD PhD, Stéphane Ducassou, MD, Thierry Leblanc, MD, Marlène Pasquet, MD, Alexandra Rousseau, Christine Ragu, PhD, Marine Cachanado, Brigitte Nelken, MD, Yves Bertrand, Gérard Michel, MD, Virginie Gandemer, Wendy Cuccuini, MD, Nicole Dastugue, MD, Odile Fenneteau, MD, Hélène Lapillonne, MD PhD, Anne Auvrignon, MD, André Baruchel, MD, Guy Leverger, MD

Blood (2014) 124 (21): 378.

https://doi.org/10.1182/blood.V124.21.378.378

Published: 2014

Journal Articles

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

Lucrecia Yanez, MD, Brenda López Pereira, Arancha Bermudez, MD, Andres Insunza, MD, Carlos Richard, MD, Mario Gonzalez Ruiz, M.D, Esmeralda Cuaresma, MD, Eulogio Conde, MD, PhD

Blood (2013) 122 (21): 5451.

https://doi.org/10.1182/blood.V122.21.5451.5451

Published: 2013

Journal Articles

A Phase I Trial Of Anti-KIR Monoclonal Antibody IPH2101 and Lenalidomide For Multiple Myeloma

Don M. Benson, Jr., MD, PhD, Adam D Cohen, MD, Craig C Hofmeister, MD, Munshi C Nikhil, MD, Sundar Jagannath, MD, Yvonne A Efebera, MD, Gary Spitzer, MD, Robert Zerbib, Pascale Andre, PhD, Shawna Oxier, Michael A. Caligiuri, MD

Blood (2013) 122 (21): 3181.

https://doi.org/10.1182/blood.V122.21.3181.3181

Published: 2013

NARROW

A Phase I, First-in-Human Study Evaluating the Safety and Preliminary Antileukemia Activity of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Other CD123-Positive Hematologic Malignancies

Management of Cytokine Release Syndrome in AML Patients Treated with Flotetuzumab, a CD123 x CD3 Bispecific Dart ® Molecule for T-Cell Redirected Therapy

A Retrospective Review of Tocilizumab for the Management of Blinatumomab (a Bispecific T Cell Engager)-Induced Cytokine Release Syndrome (CRS)

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

A 11-Year Clinical Summary of DC - CIK / NK Cell Immunotherapy for 152 Patients with Acute Myeloid Leukemia

Quinine-Induced Thrombotic Microangiopathy (Q-TMA): Frequency, Presenting Features, Outcomes

Fight for Platelets: AML Diagnosed during Dengue Fever: Case Report

Extracorporeal Photopheresis for the Treatment of Mycosis Fungoides

Low Dose Steroids Can Alleviate Blinatumomab-Associated Toxicities without Negatively Impacting Treatment Efficacy

First-in-Man CD123-Specific Chimeric Antigen Receptor-Modified T Cells for the Treatment of Refractory Acute Myeloid Leukemia

Thrombotic Microangiopathy (TMA) and Other Severe Systemic Reactions Caused By Quinine-Containing Beverages: Report of a Patient and Review of Published Reports

Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Final Results and Follow-up of a Phase I Study of the Fc Engineered CD19 Antibody XmAb®5574 (aka MOR00208) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Clinical Characteristics of Rituximab Intolerance in Patients with Waldenstrom's Macroglobulinemia

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma

Safety and Efficacy of Total Dose Infusion of Low Molecular Weight (LMW) Iron Dextran in a Large Population of Anemic Patients Across a Broad Spectrum of Diagnoses Associated with Iron Lack

Relevance of a One-Year Maintenance Therapy with Interleukin-2 in the Treatment of Childhood Acute Myeloid Leukemia: Results from the French Multicenter, Phase III, Randomized Controlled Sfce Trial, ELAM02

Progressive Increase Of Thymoglobulin Severe Infusion Reactions Used In The Conditioning Regimen Of Allogeneic Stem Cell Transplantation. Comparative Study Between 2004 and 2012

A Phase I Trial Of Anti-KIR Monoclonal Antibody IPH2101 and Lenalidomide For Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only